MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Neuro-Behavioral Therapy for Functional Movement Disorders: Conceptual Framework and Future Directions

    J. Mack, WC. Lafrance, JR. (Portland, USA)

    Objective: To explore modifications to an established, evidence-based psychological treatment for patients with psychogenic non-epileptic seizures (PNES) with the goal of studying a manualized psychotherapy…
  • MDS Virtual Congress 2021

    Be aware of pitfalls: Bioinformatic analysis of Cas9-targeted Nanopore sequencing of the RFC1 repeat in CANVAS

    I. Wohlers, H. Pott, S. Schaake, J. Trinh, H. Busch, K. Lohmann (Lübeck, Germany)

    Objective: To determine the full sequence and length of the pentanucleotide repeat in the RFC1 gene by Cas9-targeted Nanopore sequencing in patients with cerebellar ataxia…
  • MDS Virtual Congress 2021

    Genetic features and long-term outcome of Korean patients with Huntington’s disease.

    YS. Hwang, SY. Jo, SH. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the genetic characteristics and long-term outcome of Korean patients with Huntington’s disease. Background: Huntington’s disease is an autosomal dominant neurodegenerative disease, which…
  • MDS Virtual Congress 2021

    Burden of illness among US Medicare beneficiaries with late-onset Huntington’s disease

    J. Ta, S. Reiss Reddy, E. Chang, A. Exuzides, R. Gandhy, G. Yohrling (South San Francisco, USA)

    Objective: Examine healthcare resource utilization (HRU) and costs among US Medicare beneficiaries with late-onset Huntington’s disease (LoHD). Background: Huntington’s disease (HD) is a genetic, neurodegenerative…
  • MDS Virtual Congress 2021

    The Burst Duration in Cortical Myoclonus Patients, What is the Cut-Off?

    S. vd Veen, A. vd Stouwe, J. Elting, M. Tijssen (Groningen, Netherlands)

    Objective: The aim of this study is to identify a cut-off value for the burst duration of cortical myoclonus in a large cohort of myoclonus…
  • MDS Virtual Congress 2021

    Efficacy of Incobotulinumtoxin/A Treatment for Children/Adolescents with Sialorrhea associated with Neurological Disorders

    S. Berweck, H. Kim, M. Banach, A. Hanschmann, M. Althaus, M. Bonikowski (Vogtareuth, Germany)

    Objective: The SIPEXI (Sialorrhea Pediatric Xeomin Investigation) study investigated efficacy and safety of intraglandular incobotulinumtoxinA (incoBoNT/A) injections in children/adolescents with sialorrhea associated with neurological disorders…
  • MDS Virtual Congress 2021

    Stiff-person syndrome – a 15-year review at a tertiary hospital

    R. Rodrigues, L. Sousa, R. Samões, G. Cação, J. Chaves, M. Cardoso, J. Barros, E. Santos, J. Damásio (Santa Maria Feira, Portugal)

    Objective: Clinical characterization of stiff-person syndrome (SPS). Background: SPS typically presents with progressive symmetric axial and proximal limb rigidity, and episodic painful spasms triggered by…
  • MDS Virtual Congress 2021

    Spectrum of Movement Disorders among Children with Subacute Sclerosing Panencephalitis (SSPE): A Cross-sectional Study

    D. Garg, V. Kakkar, D. Kapoor, S. Sharma, S. Mukherjee, H. Pemde (New Delhi, India)

    Objective: We aimed to assess spectrum of movement disorders associated with pediatric SSPE. Background: Subacute sclerosing panencephalitis (SSPE) is a rare neurodegenerative disorder due to…
  • MDS Virtual Congress 2021

    Rapid Onset Stiff Person Syndrome

    B. Neeley, G. Pawar, R. Tripathi (Morgantown, USA)

    Objective: To present a case of rapid onset Stiff Person Syndrome (SPS) in a non-classic patient and review diagnostic considerations associated with his presentation. Background:…
  • MDS Virtual Congress 2021

    Challenges around end-of-life care for people with Parkinson’s disease in Kenya

    N. Fothergill-Misbah, J. Hooker, J. Kwasa, R. Walker (Newcastle Upon Tyne, United Kingdom)

    Objective: To explore how people living with Parkinson’s disease (PwP), and their families, in Kenya negotiate the end of life. Background: Parkinson’s disease (PD) is…
  • « Previous Page
  • 1
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley